Catchline at repeal: Schedule III controlled substances.
History: Repealed 2017 Ky. Acts ch. 61, sec. 7, effective June 29, 2017. --
Amended 2016 Ky. Acts ch. 135, sec. 5, effective April 27, 2016. -- Amended
2005 Ky. Acts ch. 99, sec. 534, effective June 20, 2005. -- Amended 1998 Ky.
Acts ch. 426, sec. 477, effective July 15, 1998. -- Amended 1992 Ky. Acts ch.
441, sec. 4, effective July 14, 1992. -- Amended 1990 Ky. Acts ch. 160, sec. 1,
effective July 13, 1990. -- Amended 1980 Ky. Acts ch. 161, sec. 2, effective July
15, 1980. -- Amended 1974 Ky. Acts ch. 74, Art. VI, sec. 107(3). -- Created 1972
Ky. Acts ch. 226, sec. 10.
Notes of Decisions
Commonwealth v. Hollingsworth, 685 S.W.2d 546 (Ky. 1984).
· cites it 3× “At the close of the Commonwealth’s case Appellee moved for a directed verdict on the grounds that the statute dealing with Schedule III drugs, KRS 218A.090 did not control pentazocine in pill form.”
Jones v. Commonwealth, 839 S.W.2d 569 (Ky. Ct. App. 1992).
“Appellant, Randy Jones, on January 27, 1989, pled guilty to trafficking in Codeine, a Schedule III Controlled Substance, in violation of KRS 218A.090, 218A.140 and 218A.990. On February 14, 1989, the Harlan Circuit Court entered a Judgment and Sentence on Plea of Guilty…”
— Ky. Rev. Stat. § 218A.090(3) — 1 case
Commonwealth v. Hollingsworth, 685 S.W.2d 546 (Ky. 1984).
“At the close of the Commonwealth’s case Appellee moved for a directed verdict on the grounds that the statute dealing with Schedule III drugs, KRS 218A.090 did not control pentazocine in pill form.”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.